Akoya Biosciences hosted "Leading and Managing Spatial Biomarker Innovations in Immuno-Oncology: Multi-Stakeholder Perspectives," a sponsored symposia during the 2021 SITC Annual Meeting. Available here is the recording from the symposia.Program SummaryAdvances in the field of spatial biomarkers in Immuno-Oncology are accelerating the pathway to precision medicine. An expert panel from Pharma, Academia, and the CRO space discussed how they are transforming this field through innovation and its impact on the spatial biomarker landscape. In this panel discussion, Drs. Robert Schreiber (Washington University School of Medicine in St. Louis), Michael Surace (AstraZeneca), and Qingyan (Sandy) Au (NeoGenomics) discussed their current research and initiatives that establish the vital role of spatial biomarkers in setting the future direction for achieving Precision Immuno-Oncology.Sponsored Symposia content and views expressed therein are those of the sponsoring organization and not of SITC.
Akoya Biosciences - Sponsored Symposia01:27:03